当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析 - 现金流量表

易明医药

(002826)

  

流通市值:35.53亿  总市值:38.86亿
流通股本:1.74亿   总股本:1.91亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金556,124,028.43355,669,205.78178,926,631.19720,443,544.82
  收到其他与经营活动有关的现金43,876,680.7118,592,457.4812,059,397.8383,503,539.05
  经营活动现金流入小计600,000,709.14374,261,663.26190,986,029.02803,947,083.87
  购买商品、接受劳务支付的现金79,027,480.8161,866,443.6738,337,179.15166,918,971.07
  支付给职工以及为职工支付的现金54,125,263.7538,379,984.722,593,496.5169,751,298.66
  支付的各项税费69,766,770.6146,395,502.1819,864,785.9996,355,500
  支付其他与经营活动有关的现金247,483,199.14165,161,318.5379,324,691.65359,348,747.93
  经营活动现金流出小计450,402,714.31311,803,249.08160,120,153.3692,374,517.66
  经营活动产生的现金流量净额149,597,994.8362,458,414.1830,865,875.72111,572,566.21
二、投资活动产生的现金流量:
  收回投资收到的现金434,000,000253,000,00020,000,000518,542,400
  取得投资收益收到的现金1,610,335.981,199,124.71148,654.982,560,952.59
  处置固定资产、无形资产和其他长期资产收回的现金净额169,380168,300168,000136,065.73
  投资活动现金流入小计435,779,715.98254,367,424.7120,316,654.98521,239,418.32
  购建固定资产、无形资产和其他长期资产支付的现金5,509,804.622,488,305.72479,20312,242,767.81
  投资支付的现金714,000,000503,000,000220,000,000490,000,000
  投资活动现金流出小计719,509,804.62505,488,305.72220,479,203502,242,767.81
  投资活动产生的现金流量净额-283,730,088.64-251,120,881.01-200,162,548.0218,996,650.51
三、筹资活动产生的现金流量:
  取得借款收到的现金22,108,171.3922,108,171.3912,501,236.1422,799,206.96
  收到其他与筹资活动有关的现金24,510,00024,510,00022,188,000-
  筹资活动现金流入小计46,618,171.3946,618,171.3934,689,236.1422,799,206.96
  偿还债务支付的现金18,138,329.7--11,000,000
  分配股利、利润或偿付利息支付的现金23,675,400.5219,259,991.77220,977.136,036,545.1
  支付其他与筹资活动有关的现金---50,025,670.68
  筹资活动现金流出小计41,813,730.2219,259,991.77220,977.1367,062,215.78
  筹资活动产生的现金流量净额4,804,441.1727,358,179.6234,468,259.01-44,263,008.82
四、汇率变动对现金及现金等价物的影响-387,406.55-145,109.96-45,223.12236,197.46
五、现金及现金等价物净增加额-129,715,059.19-161,449,397.17-134,873,636.4186,542,405.36
  加:期初现金及现金等价物余额427,398,137.38427,398,137.38427,398,137.38340,855,732.02
  期末现金及现金等价物余额297,683,078.19265,948,740.21292,524,500.97427,398,137.38
补充资料:
  净利润-37,739,129.64-47,459,998.03
  资产减值准备-283,632.71-1,193,491.93
  固定资产和投资性房地产折旧-8,773,881.43-16,480,253.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-8,773,881.43-16,480,253.14
  无形资产摊销-1,344,897.85-5,212,281.66
  处置固定资产、无形资产和其他长期资产的损失-231,283.9-44,949.62
  固定资产报废损失-2,041.87-203,943.63
  财务费用-531,319.66-445,880.34
  投资损失--1,193,874.46--3,513,562.9
  递延所得税-299,348.17-1,507,886.4
  其中:递延所得税资产减少-299,348.17-1,507,886.4
  存货的减少--7,878,719.89-17,627,018.03
  经营性应收项目的减少-131,322,954.62--14,567,976.24
  经营性应付项目的增加--109,102,144.77--8,532,006.2
  其他-104,663.45-48,010,408.77
  现金的期末余额-265,948,740.21-427,398,137.38
  减:现金的期初余额-427,398,137.38-340,855,732.02
  现金及现金等价物的净增加额--161,449,397.17-86,542,405.36
公告日期2025-10-292025-08-152025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑